Abstract Transvenous Implantable Cardioverter Defibrillator (TV-ICD) and subcutaneous
ICD (S-ICD) devices are available for patients at risk of sudden cardiac death (SCD). Both …

Background Implantable defibrillators (ICD) are highly effective in reducing arrhythmia‐
related mortality. ICD shock therapy has been shown to increase psychological distress …

ICD Sensing During VF. Introduction: We prospectively compared the performance of the
sensing and detection systems of three leading defibrillator manufacturers: Medtronic …

Introduction The extravascular implantable cardioverter‐defibrillator (EV ICD) system with
substernal lead placement is a novel nontransvenous alternative to current commercially …

The present study evaluates the incidence of various complications in implanted cardiac
defibrillators (ICD) therapy due to ventricular oversensing (VO) and its complications. From …

Background Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are
rapidly expanding. However, the subcutaneous detection and interpretation of cardiac …

DT assesses the electric integrity of the connections between the leads and pulse generator
and confirms reliable sensing, detection, and redetection in VF. opponents of DT note that …

Background The subcutaneous implantable cardioverter–defibrillator (S-ICD) remains a new
technology requiring accurate assessment of the various aspects of its functioning. Isolated …

The first human implant of the implantable cardioverter-defibrillator (ICD) in 1980 ushered in
an era of improved recognition and therapy for sudden cardiac death (SCD). 1 Initial …

Aims Despite recent improvements, inappropriate shocks emitted by implanted
subcutaneous implantable cardioverter defibrillators (S-ICDs) remain a challenge in 'real …